Salbutamol Tolerance Onset

NCT01338311 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Asthma

Interventions

DRUG: salbutamol
DRUG: Placebo

Sponsor

University of Saskatchewan